Clinical pulmonary physiology. How to report lung function tests

Similar documents
PFT Interpretation and Reference Values

The role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE

What do pulmonary function tests tell you?

Pulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?

Exercise Stress Testing: Cardiovascular or Respiratory Limitation?

Cardiopulmonary Exercise Testing Cases

Referring for specialist respiratory input. Dr Melissa Heightman Consultant respiratory physician, UCLH,WH, CNWL

Josh Stanton and Michael Epton Respiratory Physiology Laboratory, Canterbury Respiratory Research Group Christchurch Hospital

PULMONARY FUNCTION TESTS

Basic approach to PFT interpretation. Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic

PULMONARY FUNCTION TESTING. Purposes of Pulmonary Tests. General Categories of Lung Diseases. Types of PF Tests

Coexistence of confirmed obstruction in spirometry and restriction in body plethysmography, e.g.: COPD + pulmonary fibrosis

Testing Clinical Implications

6- Lung Volumes and Pulmonary Function Tests

Preoperative assessment for lung resection. RA Dyer

Pulmonary Function Testing. Ramez Sunna MD, FCCP

Understanding the Basics of Spirometry It s not just about yelling blow

Asthma COPD Overlap (ACO)

Teacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology

Content Indica c tion Lung v olumes e & Lung Indica c tions i n c paci c ties

Spirometry: an essential clinical measurement

Anyone who smokes and/or has shortness of breath and sputum production could have COPD

Respiratory Disease. Dr Amal Damrah consultant Neonatologist and Paediatrician

SPIROMETRY. Marijke Currie (CRFS) Care Medical Ltd Phone: Copyright CARE Medical ltd

Basics of Cardiopulmonary Exercise Test Interpretation. Robert Kempainen, MD Hennepin County Medical Center

Objective: Prepare NBRC candidate for CRT and WRT Content Outline

This is a cross-sectional analysis of the National Health and Nutrition Examination

Interpreting Spirometry. Vikki Knowles BSc(Hons) RGN Respiratory Nurse Consultant G & W`CCG

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?

Pulmonary Function Testing The Basics of Interpretation

Reducing lung volume in emphysema Surgical Aspects

Clinical Study Bronchial Responsiveness in Patients with Restrictive Spirometry

Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects

COMPREHENSIVE RESPIROMETRY

Sleep and Neuromuscular Disease. Sharon De Cruz, MD Tisha Wang, MD

Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene

ARF, Mechaical Ventilation and PFTs: ACOI Board Review 2018

TSANZ/ANZSRS meeting 31 Mar Clinical utility of CPET. Bhajan Singh MBBS FRACP PhD

Acute respiratory failure. Arterial blood gas assessment. finn rasmussen 2011

DLCO Webinar Q&A Dr. Christine Oropez answers post-presentation FAQs

Approach to CPET. CPET Cases. Case 1 4/4/2018. Impaired? Cardiac factors? Ventilatory factors?

Cardiopulmonary Exercise Testing: its principles, interpretation & application. DM Seminar Harshith

PULMONARY FUNCTION TEST(PFT)

Spirometry: Introduction

Triennial Pulmonary Workshop 2012

COPD in Korea. Division of Pulmonary, Allergy and Critical Care Medicine of Hallym University Medical Center Park Yong Bum

JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES

RESPIRATORY PHYSIOLOGY Pre-Lab Guide

Physiology lab (RS) First : Spirometry. ** Objectives :-

Pulmonary Function Testing

PULMONARY FUNCTION. VOLUMES AND CAPACITIES

بسم هللا الرحمن الرحيم

Aboriginal lung health and lung function. Graham Hall Telethon Kids Institute and Curtin University

Fariba Rezaeetalab Associate Professor,Pulmonologist

PULMONARY FUNCTION TESTING. By: Gh. Pouryaghoub. MD Center for Research on Occupational Diseases (CROD) Tehran University of Medical Sciences (TUMS)

Spirometry in primary care

Assessment of the Lung in Primary Care

SGRQ Questionnaire assessing respiratory disease-specific quality of life. Questionnaire assessing general quality of life

Known Allergies: Shellfish. Symptoms: abdominal pain, nausea, diarrhea, or vomiting. congestion, trouble breathing, or wheezing.

File: Spirometry-Vimeo 720p-MP3 for Audio Podcasting.mp3 Duration: 0:07:09 Date: 05/02/2014 START AUDIO

Outline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?

Pulmonary Rehabilitation in Chronic Lung Disease; Components and Organization. Prof. Dr. Müzeyyen Erk Cerrahpaşa Medical Faculty Chest Disease Dept.

Lung Pathophysiology & PFTs

The objectives of the pre-anaesthetic assessment

Objectives. Pulmonary Assessment 12/13/2017

behaviour are out of scope of the present review.

Guide to the interpretation of Cardiopulmonary Exercise Testing

A Primer on Reading Pulmonary Function Tests. Joshua Benditt, M.D.

Chronic obstructive pulmonary disease

OPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING 10/16/2018 DISCLOSURES I have no financial or other disclosures

Getting Spirometry Right It Matters! Performance, Quality Assessment, and Interpretation. Susan Blonshine RRT, RPFT, AE-C, FAARC

Update on heterogeneity of COPD, evaluation of COPD severity and exacerbation

CASE OF THE MONTH. Lung Disease in Rheumatoid Arthritis

S P I R O M E T R Y. Objectives. Objectives 3/12/2018

Cardiopulmonary Exercise Testing in Cystic Fibrosis

Pulmonary Pearls. Medical Pearls. Case 1: Case 1 (cont.): Case 1: What is the Most Likely Diagnosis? Case 1 (cont.):

SPIROMETRY TECHNIQUE. Jim Reid New Zealand

Question by Question (QXQ) Instructions for the Pulmonary Diagnosis Form (PLD)

S P I R O M E T R Y. Objectives. Objectives 2/5/2019

Life-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton

Asthma and COPD in older people lumping or splitting? Christine Jenkins Concord Hospital Woolcock Institute of Medical Research

COPD COPD. C - Chronic O - Obstructive P - Pulmonary D - Disease OBJECTIVES

Pulmonary Function Testing

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Lecture Notes. Chapter 4: Chronic Obstructive Pulmonary Disease (COPD)

PFTs ACOI Board Review 2018

COPD: early detection, screening and case-finding: what is the evidence? Prof. Jan-Willem Lammers, Md PhD Department of Respiratory Diseases

Guideline for the Diagnosis and Management of COPD

Chronic Obstructive Pulmonary Disease (COPD) Clinical Guideline

Pulmonary rehabilitation in severe COPD.

Online Data Supplement. Prevalence of Chronic Obstructive Pulmonary Disease in Korea: Results of a Population-based Spirometry Survey

Commissioning for Better Outcomes in COPD

Chronic obstructive pulmonary disease in over 16s: diagnosis and management

LUNG FUNCTION TESTING: SPIROMETRY AND MORE

Spirometry: FEVER DISEASE DIABETES HOW RELIABLE IS THIS? 9/2/2010 BUT WHAT WE PRACTICE: Spirometers are objective tools

Spirometry. Obstruction. By Helen Grim M.S. RRT. loop will have concave appearance. Flows decreased consistent with degree of obstruction.

Evaluating dyspnea: A practical approach -- When to consider cardiopulmonary exercise testing.

WORKSHOP OF LUNG FUNCTION TEST. Dr. Lo Iek Long, Department of Respiratory Medicine, CHCSJ, Macau

The Role of CPET (cardiopulmonary exercise testing) in Assessing Lung Disease in CF

COPD: Current Medical Therapy

Transcription:

Clinical pulmonary physiology or How to report lung function tests

Lung function testing A brief history Why measure? What can you measure? Interpretation/ reporting Examples and case histories Exercise tests SCE questions

A brief history of spirometry 129-200 AD Galen got a boy to blow into a bladder 1714 James Jurin measured tidal volume and vital capacity 1840 John Hutchinson measured vital capacity in 4000 people 1947 Robert Tiffineau described FEV1 and FEV1/FVC ratio 1950s-1980s Modern clinical respiratory physiology era

Respiratory physiology hall of fame

What are lung function tests for? Diagnosis Disease monitoring Assessment for therapy Therapeutic response Assessment of disability/impairment

What is available? CORE Airway function Spirometry Peak flow f/v loop Raw/SGaw Lung volumes He dilution Plethysmography Radiology Gas exchange TLCO/KCO ABGs SpO 2 EXTENDED Respiratory muscle tests Pi&Pe Max Sniff Supine VC Bronchial challenge testing Sleep SpO 2 Polysomnography Exercise testing EIA Metabolic gas exchange

Interpretation of Lung function tests Airway function FEV1 etc Physical description e.g. volumes OPINION Reference values Gas exchange TLCO & ABGs Range % predicted Standardised residual (1.64 SD)

ATS/ERS algorithm for lung function diagnosis

ERS/ATS Interpretation strategies Two tasks 1. The classification of derived values with respect to a reference population and assessment of the reliability of the data (laboratory task) 2. The integration of the obtained values into the diagnosis, therapy and prognosis for an individual (physicians task) ATS/ERS task force:standardisation of lung function testing No 1 ERJ 2005: 26:153-161

The report structure Technical Simple pattern description Relevant variations Reference values Explain anomalies Poor effort Best loop Mouthpiece leaks Coughing etc Quality control VCs equal VA < TLC Suggestions for further investigation Clinician s Answer the question Values in context Confirm diagnosis Suggest differential diagnosis Further investigation Advice on further management

Reference Equations Obtained from healthy subjects Gender, age and height Make your own Use reference equations for local population Use ECCS or ATS Ethnic correction GLI (Global, multi ethnic, all ages)

Lung function: categories of interpretation Obstructive FEV1/VC Loop Raw TLC RV/TLC Gas trapping (TLC-VA) COPD, asthma, emphysema Big lungs Restrictive FEV1/VC TLC, RV TLCO (KCO) ILD, sarcoid etc Small lungs Constrictive TLC (n RV) KCO Muscle weakness, obesity, scoliosis Squashed lungs

Common requests SOB? Cause (COPD, ILD) Is it asthma or COPD? Upper airway obstruction? Fit for surgery? Disease progression? Confirm diagnosis What is the prognosis?

Is it asthma or COPD? Young patient <20 pack year smoking history Airway obstruction PFTS may be normal! Good bronchodilator response (normal or 600ml) May need to suggest Explore the history further Peak flow monitoring PC20 etc FeNO/ Sputum eosinophils

Is it upper airway obstruction? Low FEV1/ FVC % ( not helpful ) Shape of spirogram(slow rise) Appearance of flow volume loop Airways resistance (Raw or SGaw) Empey Index (FEV1 ml/pfr L/Min) >8 You can t always tell!

Upper airway obstruction

Fit for surgery? Beware! The anaesthetist knows best Describe the situation Point out the unusual (UAO etc) Suggest how treatment can be improved Some operations have less effect on lung function than others Eyes and prostate ok Abdominal and thoracic surgery worse Prediction pathways (SWT, V/Q etc) Some surgery can improve lung function Decortication Bullectomy LVRS Transplantation

Prevalence of COPD is overestimated > 50years

Bronchodilator response Various definitions 12% change in FEV1 >200ml FEV >8% predicted FEV1

Miscellaneous reporting pitfalls Look at the loop! (minor abnormalities,site & nature of AO) Bronchodilator response in all? (not just FEV1) What sort of TLC? BOX> He Dilution> VA TLCO ( remember the haemoglobin etc) Reference values (the normal abnormal) Ethnic origin (10%)

Case 1 SOBE?

Case 1 Report Context Older lady, ex smoker, BMI 33 Airways Unobstructed, restrictive pattern, lower range of normal. Loop unhelpful Lung Volumes TLC 57% predicted, RV <50% predicted Gas transfer Low TLCO, relatively preserved KCO Diagnosis and advice?

Case 1 Report Lung function test compatible with a severe restrictive disorder. Low RV suggests intrinsic lung disease e.g IPF. Arterial blood gases would be helpful Suggest repeat PFTs after further investigation to monitor progress or treatment response (VC 68%)

Case 2 Previous abnormal CXR Progress?

Case Report 2 Context Age 33, BMI 23, Ex smoker, Previous lung function tests. Airways Previous tests shown mild airflow obstruction. Current test shows a restrictive pattern with recent fall in values. Still mild airflow obstruction on loop. Lung Volumes Sudden fall, TLC 60% predicted, RV <50% predicted Gas transfer Low TLCO, preserved KCO. Diagnosis and advice?

Case Report 2 Previous PFTs show a mild mixed picture (AO + low RV) No features of upper airway obstruction Significant development of more severe restrictive pattern Mixed picture compatible with ILD and smoking history or sarcoidosis Suggest repeat tests after treatment with corticosteroids (two months)

Case 3 Progressive dyspnoea

Case Report 3 Context Age 22 BMI 24, never smoked, lung function tests two years previously Airways Previous restrictive pattern worsened over time. FEV1 now 38% pred. Lung Volumes Low TLC (39%Pred), RV/TLC ratio 32% Gas transfer Low TLCO, High KCO. Diagnosis and advice?

Case Report 3 Severe restrictive pattern with progressive deterioration Preservation of RV/TLV ratio and KCO suggests external restriction (constrictive pattern) Causes might include muscle weakness, scoliosis etc FEV1< 40% predicted indicates that ventilatory failure may be imminent Suggest muscle studies, ABGs and sleep study as appropriate Why is the TLCO low?

Nocturnal hypoventilation

Case 4 Suitable for surgery?

Case Report 4 Context Age 69, BMI 21, Previous lung function tests. Airways Severe airflow obstruction, FEV1 23% predicted Pressure dependent airway collapse on loop No bronchodilator response performed Lung Volumes Gross hyperinflation on plethysmography RV/TLC ratio 69% TLC-VA > 500ml (3L gas trapping) Gas transfer TLCO 25% predicted, low KCO, ABGs? Diagnosis and advice?

Case Report 4 Severe airflow obstruction with features of emphysema (loop and KCO) Gross hyperinflation and gas trapping Progressive deterioration Potentially suitable for LVRS (hyperinflation, FEV1, KCO>20% predicted) Other helpful investigations would include ABGs, SWT and imaging

Exercise is good for you

The uses of cardiopulmonary exercise testing (performance testing, diagnostic, laboratory and field) The differential diagnosis of breathlessness The objective assessment of impairment/disability Guide to prognosis The assessment of therapeutic intervention (drugs/rehab/lvrs) Preoperative assessment Training prescription

Spirometry and exercise performance

The context of exercise assessment in lung disease Scientific exploration Functional performance measures Physical (domestic) activity Methods Laboratory (CPET) Laboratory (endurance) ADL Questionnaires Field testing (6MWD, ISWT,ESWT) Physical activity monitors Questionnaires (MRC, PFSS)

Methods of objective exercise testing in clinical practice Laboratory (Various platforms) Symptom-limited incremental test Constant workload (power) test Field (walking)tests Six minute walk Incremental shuttle walk test Endurance shuttle walk tests

Laboratory based exercise tests (CPET) Gold standard Precise physiological data Expensive

Incremental exercise response in health Metabolic threshold VE VO 2 VO 2maximal %VO 2max sustainable HR/CO VT Time/workload t

CPET for diagnosis for diagnosis of unexplained breathlessness Heart or lungs? Lack of fitness? Dysfunctional breathing? Obesity? Normal but uncompetitive

Interpretation of the Symptom Limited Maximal Incremental Exercise Test Has the subject made a good effort? Have they achieved normal values? Why did they stop? How did they get there? (physiological response)

Has the subject made a good effort? Plateau of VO 2 Max Patient exhaustion HR or VE close to predicted maximum Blood lactate > 4 mmol/l Respiratory Exchange Ratio >1.2

Reference values for exercise tests (VO 2) E.g. Jones N.L. Am Rev Respir Dis 1985 131,700-8 Age and Gender (ht and wt) Mostly USA Nearly all on cycle Small numbers (50) Mixed active and sedentary See Cooper for combined equations

Why did they stop? Identification of a ventilatory or cardiac limit to exercise Ventilatory VE max > 80% VE max predicted (MVV) Ventilatoryreserve (VE max pred-ve max) < 11 L/min VT > 50-70% of VC Breathing frequency > 50 min PaCO 2 rise Cardiovascular Chest pain High heart rate (220-age) Low Oxygen pulse Low AT

Interpretation Algorithmic (Wasserman) Determined by VO 2 peak and AT Can be computerised Analytical Examination of data Pattern recognition Fixed point comparison (VO 2 1.0 L/min, VE 30 L/min)

Patterns of exercise abnormality VO 2 PEAK AT VD/VT SaO 2 O 2 pulse VO 2 /HR VE/VO 2 HRR Cardiac Disease (may be limited by chest pain) Low Low Normal Normal Low High Nil Pulmonary vascular disease Low Low High Low Low High Nil Airway Obstruction Low High or absent High Normal Normal High High Interstitial Lung Disease Low High or absent High Low Normal High (High Bf and low VT) High Chest Wall Restriction Low High or absent Normal Normal/low Normal Normal (High Bf and low VT High Poor effort Low High or Absent Normal Normal (or high) Normal Normal High

SCE Questions